CANS.F Stock Overview
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Willow Biosciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.065 |
| 52 Week High | CA$0.11 |
| 52 Week Low | CA$0.049 |
| Beta | 1.07 |
| 1 Month Change | -9.49% |
| 3 Month Change | -21.78% |
| 1 Year Change | -39.49% |
| 3 Year Change | -93.91% |
| 5 Year Change | -96.06% |
| Change since IPO | -96.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| CANS.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -0.4% | -4.2% | -3.7% |
| 1Y | -39.5% | -2.0% | 20.5% |
Return vs Industry: CANS.F underperformed the US Biotechs industry which returned -2% over the past year.
Return vs Market: CANS.F underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| CANS.F volatility | |
|---|---|
| CANS.F Average Weekly Movement | 13.4% |
| Biotechs Industry Average Movement | 11.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CANS.F's share price has been volatile over the past 3 months.
Volatility Over Time: CANS.F's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 19 | Chris Savile | www.willowbio.com |
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation. Willow Biosciences Inc. is headquartered in Calgary, Canada.
Willow Biosciences Inc. Fundamentals Summary
| CANS.F fundamental statistics | |
|---|---|
| Market cap | US$7.84m |
| Earnings (TTM) | -US$9.47m |
| Revenue (TTM) | US$851.94k |
9.7x
P/S Ratio-0.9x
P/E RatioIs CANS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CANS.F income statement (TTM) | |
|---|---|
| Revenue | CA$1.17m |
| Cost of Revenue | CA$6.80m |
| Gross Profit | -CA$5.63m |
| Other Expenses | CA$7.40m |
| Earnings | -CA$13.03m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.10 |
| Gross Margin | -480.20% |
| Net Profit Margin | -1,111.69% |
| Debt/Equity Ratio | 19.7% |
How did CANS.F perform over the long term?
See historical performance and comparison